Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

A new study led by York University, looking at the health data of nearly 15,000 people enrolled in a medically supervised ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

President Donald Trump's executive order directs pharmaceutical companies to lower their prices to levels closer to those ...

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

Medications such as Wegovy, Mounjaro and Ozempic were found to have disease-prevention qualities beyond their weight-loss ...

The first head-to-head trial of obesity drugs reveals a clear winner for effective weight loss. But how does it work, and what are the long-term effects? Anna Magee reports ...